Literature DB >> 21598248

Transition from cylindroma to spiradenoma in CYLD-defective tumours is associated with reduced DKK2 expression.

Neil Rajan1, John Burn, James Langtry, Maya Sieber-Blum, Christopher J Lord, Alan Ashworth.   

Abstract

Patients carrying heterozygous germline truncating mutations in the CYLD gene develop multiple primary hair follicle-related tumours. A highly patterned tumour, termed cylindroma, and a highly disorganized tumour, termed spiradenoma, may both develop in the same patient. Furthermore, histological features of both tumour types have been described within the same tumour specimen. We used three-dimensional computer-aided reconstruction of these tumours to demonstrate contiguous growth of cylindromas into spiradenomas, thus suggesting a transition between the two tumour types. To explore factors that may influence cutaneous tumour patterning, genome-wide transcriptomic analysis of 32 CYLD-defective tumours was performed. Overexpression of the Wnt/β-catenin signalling pathway was observed relative to normal perilesional tissue. Morphometric analysis was used to investigate the relationship between Wnt pathway-related gene expression and tumour organization. This revealed an association between reduced Dickkopf 2 (DKK2-a negative regulator of the Wnt/β-catenin signalling pathway) expression and loss of tumour patterning. Reduced DKK2 expression was associated with methylation of the DKK2 gene promoter in the majority of tumour samples assayed. RNA interference-mediated silencing of DKK2 expression in cylindroma primary cell cultures caused an increase in colony formation, cell viability, and anchorage-independent growth. Using these data, we propose a model where epigenetic programming may influence tumour patterning in patients with CYLD mutations.
Copyright © 2011 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21598248     DOI: 10.1002/path.2896

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  8 in total

1.  Infiltrative recurrent eccrine spiradenoma of the anterior neck treated using Mohs micrographic surgery.

Authors:  Rajib R Rahim; Neil Rajan; James A A Langtry
Journal:  Dermatol Surg       Date:  2013-10-01       Impact factor: 3.398

2.  A mutational hotspot in CYLD causing cylindromas: a comparison of phenotypes arising in different genetic backgrounds.

Authors:  Nikoletta Nagy; Neil Rajan; Katalin Farkas; Agnes Kinyó; Lajos Kemény; Márta Széll
Journal:  Acta Derm Venereol       Date:  2013-11       Impact factor: 4.437

3.  Identification and characterization of a small-molecule inhibitor of Wnt signaling in glioblastoma cells.

Authors:  Alessandra De Robertis; Silvia Valensin; Marco Rossi; Patrizia Tunici; Margherita Verani; Antonella De Rosa; Cinzia Giordano; Maurizio Varrone; Arianna Nencini; Carmela Pratelli; Tiziana Benicchi; Annette Bakker; Jeffrey Hill; Kanda Sangthongpitag; Vishal Pendharkar; Boping Liu; Fui Mee Ng; Siew Wen Then; Shi Jing Tai; Seong-Moon Cheong; Xi He; Andrea Caricasole; Massimiliano Salerno
Journal:  Mol Cancer Ther       Date:  2013-04-25       Impact factor: 6.261

4.  The cylindromatosis gene product, CYLD, interacts with MIB2 to regulate notch signalling.

Authors:  Neil Rajan; Richard J R Elliott; Alice Smith; Naomi Sinclair; Sally Swift; Christopher J Lord; Alan Ashworth
Journal:  Oncotarget       Date:  2014-12-15

5.  Diverse presentations of cutaneous mosaicism occur in CYLD cutaneous syndrome and may result in parent-to-child transmission.

Authors:  Majid Arefi; Valerie Wilson; Siobhan Muthiah; Simon Zwolinski; Dalvir Bajwa; Paul Brennan; Katie Blasdale; David Bourn; John Burn; Mauro Santibanez-Koref; Neil Rajan
Journal:  J Am Acad Dermatol       Date:  2019-05-11       Impact factor: 11.527

6.  Case report of syndromic multiple spiradenomas due to biallelic functional loss of CYLD.

Authors:  Colleen J Beatty; Ahmed Yousaf; Abdullah Al-Bouri; Andrew D Thompson; Katrin Kiavash; Michael S Kolodney
Journal:  JAAD Case Rep       Date:  2022-01-20

7.  Growing Asymptomatic Nodule on the Ear.

Authors:  Alyssa Miceli; Ann Church; Sarah Ferrer-Bruker
Journal:  Indian Dermatol Online J       Date:  2018 Mar-Apr

8.  Epigenetic modifiers DNMT3A and BCOR are recurrently mutated in CYLD cutaneous syndrome.

Authors:  Helen R Davies; Kirsty Hodgson; Edward Schwalbe; Jonathan Coxhead; Naomi Sinclair; Xueqing Zou; Simon Cockell; Akhtar Husain; Serena Nik-Zainal; Neil Rajan
Journal:  Nat Commun       Date:  2019-10-17       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.